Search
for
Sort by
Research 361–390 of 1000+
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- FFA Patient Profile Analysis Based on the Authors’ Observations and a Review of the Literature—An Original Survey
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Association between postoperative nadir hematocrit and mortality within 28-day after coronary artery bypass grafting: A retrospective cohort study based on the MIMIC-IV database
- Association between androgenetic alopecia and psychological well-being: a systematic review and meta-analysis
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- Response to “Lack of association between comorbidities and central centrifugal cicatricial alopecia: a retrospective cohort study of 153 patients”
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study
- An unusual case of Anasarca-Rapunzel syndrome
- Clinical and sociodemographic features of alopecia areata in five Colombian cities: an analysis of the RENAAC registry
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Topical delivery of nanoemulsions for skin cancer treatment
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- Proopiomelanocortin (POMC) and Psychodermatology
- Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Metabolism and skin diseases